Andrew D. Lipman Sells 2,000 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) Stock

Nu Skin Enterprises, Inc. (NYSE:NUS) Director Andrew D. Lipman sold 2,000 shares of the company’s stock in a transaction dated Thursday, April 25th. The stock was sold at an average price of $12.34, for a total value of $24,680.00. Following the completion of the transaction, the director now directly owns 25,225 shares of the company’s stock, valued at approximately $311,276.50. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Nu Skin Enterprises Price Performance

Shares of NUS stock traded down $0.23 during trading hours on Thursday, reaching $12.25. The company had a trading volume of 470,032 shares, compared to its average volume of 753,528. The stock has a fifty day moving average of $12.80 and a 200-day moving average of $16.38. The company has a market capitalization of $605.15 million, a price-to-earnings ratio of 69.23 and a beta of 1.11. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.28 and a current ratio of 2.13. Nu Skin Enterprises, Inc. has a 12-month low of $11.84 and a 12-month high of $40.68.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Wednesday, February 14th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.29 by $0.08. Nu Skin Enterprises had a return on equity of 10.73% and a net margin of 0.44%. The business had revenue of $488.64 million for the quarter, compared to analyst estimates of $479.35 million. On average, equities analysts anticipate that Nu Skin Enterprises, Inc. will post 1.13 earnings per share for the current year.

Nu Skin Enterprises Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 6th. Stockholders of record on Monday, February 26th were issued a dividend of $0.06 per share. The ex-dividend date of this dividend was Friday, February 23rd. This represents a $0.24 dividend on an annualized basis and a dividend yield of 1.96%. Nu Skin Enterprises’s dividend payout ratio is currently 133.34%.

Institutional Investors Weigh In On Nu Skin Enterprises

Several hedge funds and other institutional investors have recently added to or reduced their stakes in NUS. GAMMA Investing LLC purchased a new position in Nu Skin Enterprises during the fourth quarter worth about $33,000. CWM LLC increased its holdings in Nu Skin Enterprises by 5,838.9% in the 3rd quarter. CWM LLC now owns 2,138 shares of the company’s stock valued at $45,000 after purchasing an additional 2,102 shares during the last quarter. Signaturefd LLC raised its position in Nu Skin Enterprises by 240.7% in the third quarter. Signaturefd LLC now owns 3,996 shares of the company’s stock valued at $85,000 after purchasing an additional 2,823 shares during the period. Counterpoint Mutual Funds LLC acquired a new position in Nu Skin Enterprises during the third quarter worth $124,000. Finally, New Mexico Educational Retirement Board purchased a new position in shares of Nu Skin Enterprises during the first quarter worth $145,000. Institutional investors and hedge funds own 82.84% of the company’s stock.

Wall Street Analyst Weigh In

NUS has been the topic of a number of recent analyst reports. StockNews.com lowered Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Saturday, February 24th. DA Davidson lowered their price objective on Nu Skin Enterprises from $29.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday, January 5th. Four investment analysts have rated the stock with a hold rating, According to data from MarketBeat.com, Nu Skin Enterprises currently has an average rating of “Hold” and an average price target of $23.67.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.